{"abstract": "Sanofi-Aventis\u2019s top shareholders, L\u2019Oreal and Total, have reservations about the drug maker\u2019s plans to buy Genzyme and are concerned that it does not overpay, bankers said.", "web_url": "https://dealbook.nytimes.com/2010/08/26/top-2-sanofi-shareholders-seen-wary-on-genzyme-bid/", "snippet": "Sanofi-Aventis\u2019s top shareholders, L\u2019Oreal and Total, have reservations about the drug maker\u2019s plans to buy Genzyme and are concerned that it does not overpay, bankers said.", "lead_paragraph": "Sanofi-Aventis\u2018s top shareholders L\u2019Oreal and Total have reservations about the drug maker\u2019s plans to buy Genzyme and are concerned that it does not overpay, bankers told Reuters.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Top 2 Sanofi Shareholders Seen Wary on Genzyme Bid", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Genzyme Corp", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Sanofi-Aventis SA", "rank": 2, "major": "N"}], "pub_date": "2010-08-26T06:45:29+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "", "_id": "nyt://article/d23d2b14-908c-5475-b701-626998df3833", "word_count": 163, "uri": "nyt://article/d23d2b14-908c-5475-b701-626998df3833"}